TABLE 2

Comparison of the SAMBA semi-Q and Roche TaqMan v2 results for 488 clinical samples from London (n = 134), Malawi (n = 200), and Uganda (n = 154)a

Sample source and SAMBA Semi-Q result (copies/ml)No. with result with Roche TaqMan v2 (copies/ml)
<1,000>1,000
London
    <1,000951
    >1,000236
Malawi
    <1,0001460
    >1,000450
Uganda
    <1,000915
    >1,000355
  • a Concordance between the two tests was 96.9% (473/488) overall, 97.8% (131/134) in London, 98.0% (196/200) in Malawi, and 94.8% (146/154) in Uganda.